Invited Speaker
37th TROG Cancer Research Annual Scientific Meeting 2025
Days
Tuesday, 18th March
Wednesday, 19th March
Thursday, 20th March
Friday, 21st March
Search
Speakers
TROG 17.02 OUTRUN: Randomised phase II trial of Osimertinib with or without stereotactic radiosurgery for EGFR mutated NSCLC with brain metastases - Update (Cat A, Closed)
(#45)
Yu Yang Soon
1
National University Cancer Institute, Singapore, Singapore, SINGAPORE
Content is not available at the time of publishing.